Delivery Order SPE2DR25D2103-SPE2DR26F91UF
- Not listed
- The Defense Logistics Agency awarded a $5,771.92 delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3ml vials. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 2, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the company's demonstrated capability to compete openly for...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $91,757.94 for Ozempic 1 mg/dose (4 mg/3 ml) 3 ml vials on December 1, 2025, with an ultimate completion date of December 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The order represents a single pharmaceutical supply transaction under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) vials valued at $6,821.38. This non-competitive, firm fixed-price delivery order is due for completion by December 12, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with DLA, supporting federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials, with a ceiling value of $6,644.70 and an ultimate completion date of December 4, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's broader pharmaceutical supply contract vehicle. The place of performance is listed as Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials, with a ceiling value of $10,899.38. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is expected to reach ultimate completion by December 9, 2025. The delivery order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's headquarters location. This...
- The Defense Logistics Agency awarded a delivery order valued at $15,747.50 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml vials. This firm fixed price contract, awarded on November 20, 2025, with an ultimate completion date of November 21, 2025, represents a non-set-aside competitive award. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $35,750.42 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This competitive award, issued on November 26, 2025, with an ultimate completion date of November 28, 2025, utilizes a firm fixed-price contract type with no set-aside designation. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, AmerisourceBergen's corporate headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $17,177.13 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This competitively awarded, firm fixed-price delivery order was issued on December 10, 2025, with an ultimate completion date of December 11, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $11,833.28 on October 27, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials, with completion scheduled for October 28, 2025. The contract utilizes firm fixed-price pricing and carries no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,426.72 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL quantities. This competitive, non-set-aside delivery order was awarded on December 10, 2025, with an ultimate completion date of December 11, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract utilizes firm fixed pricing as the pricing mechanism....
- SPE2DR25D2103Indefinite Delivery Contract
- SPE2DR25D2103-SPE2DR26F91UFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $75,030.67 to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials. This is a firm fixed price, non-set-aside contract with a completion date of December 17, 2025, and will be performed at AmerisourceBergen's location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger contract vehicle with the DLA. This delivery order is issued under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement across military and veteran healthcare systems. The IDC enables the company to supply a comprehensive range of pharmaceutical products, medical devices, and specialty medications to support military healthcare programs globally, including serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $75.0k | 12/15/25 |